P

Inventor

HELLSTRAND KRISTOFFER

SE16 patents
⚠️ This page may combine multiple inventors who share the name “HELLSTRAND KRISTOFFER”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

MAXIM PHARM INC

15 patents
US6242473B1Jun 5, 2001

Treatment and prevention of reactive oxygen metabolite-mediated cellular damage

MAXIM PHARM INC33 citations95
US5728378AMar 17, 1998

Preparation for activation of natural killer cells (NK-cells), said preparation containing interferon-alpha and histamine, serotonin, amines or substances with corresponding receptor activity

MAXIM PHARM INC23 citations92
US6407133B2Jun 18, 2002

Treatment and prevention of reactive oxygen metabolite-mediated cellular damage

MAXIM PHARM INC12 citations81
US6730692B2May 4, 2004

Treatment and prevention of reactive oxygen metabolite-mediated cellular damage

MAXIM PHARM INC4 citations73
US6305380B1Oct 23, 2001

Method for treatment of cancer and infectious disease

MAXIM PHARM INC8 citations73
US6221893B1Apr 24, 2001

Administration of histamine for therapeutic purposes

MAXIM PHARM INC5 citations73
US6071942AJun 6, 2000

Elevation of circulating blood histamine levels

MAXIM PHARM INC9 citations73
US5961969AOct 5, 1999

Stable circulating histamine levels

MAXIM PHARM INC8 citations73
US6893633B2May 17, 2005

Methods and compositions for promoting the maturation of monocytes

MAXIM PHARM INC8 citations72
US6790440B2Sep 14, 2004

Methods and compositions for promoting the maturation of monocytes

MAXIM PHARM INC7 citations72
US6613788B1Sep 2, 2003

Elevation of circulating blood histamine levels

MAXIM PHARM INC2 citations62
US6462067B1Oct 8, 2002

Treatment and prevention of reactive oxygen metabolite-mediated cellular damage

MAXIM PHARM INC3 citations62
US6155266ADec 5, 2000

Method for treatment of cancer and infectious disease

MAXIM PHARM INC3 citations62
US6821510B2Nov 23, 2004

Methods and compositions for promoting the maturation of monocytes

MAXIM PHARM INC3 citations61
US6003516ADec 21, 1999

Method for treatment of cancer and infectious disease

MAXIM PHARM INC1 citations51

MAXIM PHARMACEUTICALS

1 patent